Search details
1.
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.
N Engl J Med
; 374(4): 311-22, 2016 Jan 28.
Article
in English
| MEDLINE | ID: mdl-26639348
2.
In vivo study of the role of α6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin.
FASEB J
; 31(1): 192-202, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27682206
3.
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study.
Lancet Oncol
; 18(2): 230-240, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-28089635
4.
Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents.
Oncologist
; 22(11): 1283-1291, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28851760
5.
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Lancet Oncol
; 17(6): 768-778, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-27178240
6.
Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency.
Sci Rep
; 10(1): 18361, 2020 10 27.
Article
in English
| MEDLINE | ID: mdl-33110151
7.
Visual Evoked Potentials in Glaucoma and Alzheimer's Disease.
Methods Mol Biol
; 1695: 69-80, 2018.
Article
in English
| MEDLINE | ID: mdl-29190019
8.
The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model.
Neurobiol Aging
; 67: 181-188, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29735432
9.
Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 24(18): 4371-4379, 2018 09 15.
Article
in English
| MEDLINE | ID: mdl-29895707
10.
Synaptic Dysfunction in Alzheimer's Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection.
Front Cell Neurosci
; 11: 53, 2017.
Article
in English
| MEDLINE | ID: mdl-28289378
11.
Generation of a new mouse model of glaucoma characterized by reduced expression of the AP-2ß and AP-2δ proteins.
Sci Rep
; 7(1): 11140, 2017 09 11.
Article
in English
| MEDLINE | ID: mdl-28894266
12.
Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation.
Cancer Chemother Pharmacol
; 58(5): 585-93, 2006 Nov.
Article
in English
| MEDLINE | ID: mdl-16680463
13.
Conjunctivally Applied BDNF Protects Photoreceptors from Light-Induced Damage.
Transl Vis Sci Technol
; 4(6): 1, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-27190697
14.
Rescue of retinal function by BDNF in a mouse model of glaucoma.
PLoS One
; 9(12): e115579, 2014.
Article
in English
| MEDLINE | ID: mdl-25536045
15.
Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.
Clin Cancer Res
; 17(16): 5257-67, 2011 Aug 15.
Article
in English
| MEDLINE | ID: mdl-21712447
16.
Association between osteonecrosis of the jaws and chronic high-dosage intravenous bisphosphonates therapy.
J Craniofac Surg
; 17(5): 876-9, 2006 Sep.
Article
in English
| MEDLINE | ID: mdl-17003614
17.
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
Ann Surg Oncol
; 13(1): 58-65, 2006 Jan.
Article
in English
| MEDLINE | ID: mdl-16372158
Results
1 -
17
de 17
1
Next >
>>